|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 0.8600 USD | -4.09% |
|
-13.39% | -83.99% |
| 09-23 | Compass Therapeutics Shares Drop After Downgrade From Wedbush | MT |
| 09-23 | Wedbush Downgrades Compass Therapeutics to Neutral From Outperform, Cuts Price Target to $1 From $5 | MT |
Chart calendar Compass Therapeutics, Inc.
Upcoming events on Compass Therapeutics, Inc.
No events available
Past events on Compass Therapeutics, Inc.
| 2026-06-10 | Annual General Meeting | 09:00 |
| 2026-06-10 | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-04-27 | Information meeting | 08:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,85 0,80 6.25% | 0,00 0,00 - | 0,00 | 6,51 | 44,8 |
|
EBITDA Million USD | Released Forecast Spread | -49,7 -47,3 -5.11% | -56,0 -52,0 -7.76% | -72,6 -77,2 6.01% | -100,0 | -112 | -125 |
|
EBIT Million USD | Released Forecast Spread | -50,4 -48,6 -3.66% | -56,6 -54,2 -4.43% | -72,8 -72,2 -0.83% | -98,6 | -113 | -103 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -42,5 -42,9 0.88% | -49,4 -47,8 -3.26% | -66,5 -66,3 -0.26% | -92,5 | -109 | -96,0 |
|
Net income Million USD | Released Forecast Spread | -42,5 -42,4 -0.23% | -49,4 -48,4 -2.11% | -66,5 -66,4 -0.18% | -93,3 | -112 | -93,5 |
|
EPS USD | Released Forecast Spread | -0,33 -0,33 0.86% | -0,36 -0,35 -2.86% | -0,42 -0,42 0.45% | -0,50 | -0,56 | -0,44 |
| Announcement Date | 21/03/24 | 27/02/25 | 05/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 | 2028 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 -0,64 - | 0,00 -0,51 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,18 | 0,48 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -16,4 -12,0 -36.91% | -17,8 -16,9 -5.64% | -21,0 -18,5 -13.64% | -15,8 -23,0 31.31% | -18,0 -22,3 19.4% | -20,3 -19,6 -3.31% | -27,0 -21,4 -26.27% | -25,6 | -27,1 | -22,3 | -26,8 | -22,9 | -23,3 | -23,7 | -22,7 |
|
EBIT Million USD | Released Forecast Spread | -16,6 -14,1 -17.77% | -18,0 -15,8 -14.01% | -21,1 -18,3 -14.93% | -15,8 -20,8 23.92% | -18,0 -17,4 -3.36% | -20,3 -18,7 -8.74% | -27,0 -21,0 -28.62% | -24,4 | -25,9 | -25,0 | -27,4 | -26,5 | -27,2 | -23,7 | -27,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,0 -13,0 -15.23% | -16,6 -15,0 -10.56% | -19,9 -17,4 -14.38% | -14,3 -19,8 28.13% | -15,7 -15,8 0.65% | -18,3 -17,2 -6.43% | -25,2 -19,8 -26.81% | -23,8 | -25,3 | -24,3 | -26,7 | -25,3 | -25,5 | -23,7 | -27,7 |
|
Net income Million USD | Released Forecast Spread | -15,0 -13,6 -10.36% | -16,6 -15,6 -6.7% | -19,9 -17,4 -13.98% | -14,3 -20,0 28.69% | -15,7 -15,7 -0.21% | -18,3 -18,0 -1.67% | -25,2 -20,3 -23.86% | -23,7 | -26,0 | -24,4 | -26,8 | -26,0 | -26,5 | -23,7 | -27,7 |
|
EPS USD | Released Forecast Spread | -0,11 -0,10 -13.4% | -0,12 -0,11 -8.11% | -0,14 -0,12 -12.9% | -0,08 -0,14 42.48% | -0,09 -0,09 0% | -0,10 -0,10 -1.35% | -0,13 -0,11 -19.63% | -0,13 | -0,14 | -0,13 | -0,14 | -0,13 | -0,13 | -0,09 | -0,10 |
| Announcement Date | 27/02/25 | 08/05/25 | 11/08/25 | 05/11/25 | 05/03/26 | 05/05/26 | 06/08/26 | - | - | - | - | - | - | - | - |
| 2026-10-21 |  | Information meeting | 09:00 |
| 2026-10-22 | | Earnings release - Q3 2026 | |
| 2026-10-22 | | Earnings presentation | 08:30 |
| 2026-10-23 | | Extraordinary General Meeting | 02:00 |
| 2026-10-25 | | Board of Directors Meeting | |
| 2026-10-25 | | Board of Directors Meeting | |
| 2026-10-26 | | Earnings release - Q3 2026 | |
| 2026-10-26 | | Earnings release - Q3 2026 | |
| 2026-10-26 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-27 | | Earnings release - Q3 2026 |
Past sector events for Compass Therapeutics, Inc.
| 2026-10-14 | | Information meeting | 14:30 |
| 2026-10-14 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-14 | | Sales and Revenue Release - Q3 2026 | |
| 2026-10-14 | | Information meeting | 08:00 |
| 2026-10-13 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-13 | | Information meeting | 16:30 |
| 2026-10-13 | | Extraordinary General Meeting | 22:00 |
| 2026-10-07 | | Extraordinary General Meeting | 09:00 |
| 2026-10-07 | | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-10-06 | | Information meeting | 10:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
- Calendar Compass Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
